{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T19:48:52Z","timestamp":1779133732878,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T00:00:00Z","timestamp":1563494400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T00:00:00Z","timestamp":1563494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000032","name":"Institute of Infection and Immunity","doi-asserted-by":"publisher","award":["TMI-138656"],"award-info":[{"award-number":["TMI-138656"]}],"id":[{"id":"10.13039\/501100000032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"crossref","award":["4D43TW009578-04"],"award-info":[{"award-number":["4D43TW009578-04"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000085","name":"Ontario HIV Treatment Network","doi-asserted-by":"publisher","award":["Endowed Chair in HIV Research"],"award-info":[{"award-number":["Endowed Chair in HIV Research"]}],"id":[{"id":"10.13039\/501100000085","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13063-019-3545-7","type":"journal-article","created":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T12:02:50Z","timestamp":1563537770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Protocol for a randomized clinical trial exploring the effect of antimicrobial agents on the penile microbiota, immunology and HIV susceptibility of Ugandan men"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3702-5722","authenticated-orcid":false,"given":"Ronald M.","family":"Galiwango","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Bagaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliet","family":"Mpendo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vineet","family":"Joag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda","family":"Okech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annet","family":"Nanvubya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Ssetaala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moses","family":"Muwanga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupert","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,19]]},"reference":[{"key":"3545_CR1","doi-asserted-by":"publisher","first-page":"S159","DOI":"10.1093\/cid\/civ091","volume":"60","author":"R Baggaley","year":"2015","unstructured":"Baggaley R, Doherty M, Ball A, Ford N, Hirnschall G. The strategic use of antiretrovirals to prevent HIV infection: a converging agenda. Clin Infect Dis. 2015;60:S159\u201360.","journal-title":"Clin Infect Dis"},{"key":"3545_CR2","doi-asserted-by":"crossref","unstructured":"Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, Corbelli GM, Estrada V, Geretti AM, Beloukas A, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 2019;393(10189):2428\u201338.","DOI":"10.1016\/S0140-6736(19)30418-0"},{"key":"3545_CR3","volume-title":"Global HIV & AIDS statistics \u2014 2018 fact sheet","author":"UNAIDS","year":"2018","unstructured":"UNAIDS: Global HIV & AIDS statistics \u2014 2018 fact sheet. 2018."},{"key":"3545_CR4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1473-3099(15)00536-8","volume":"16","author":"TenoRes Study G","year":"2016","unstructured":"TenoRes Study G. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study. Lancet Infect Dis. 2016;16:565\u201375.","journal-title":"Lancet Infect Dis"},{"key":"3545_CR5","doi-asserted-by":"publisher","first-page":"e298","DOI":"10.1371\/journal.pmed.0020298","volume":"2","author":"B Auvert","year":"2005","unstructured":"Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2:e298.","journal-title":"PLoS Med"},{"key":"3545_CR6","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0140-6736(07)60312-2","volume":"369","author":"RC Bailey","year":"2007","unstructured":"Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, Williams CF, Campbell RT, Ndinya-Achola JO. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369:643\u201356.","journal-title":"Lancet"},{"key":"3545_CR7","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(07)60313-4","volume":"369","author":"RH Gray","year":"2007","unstructured":"Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, Kiwanuka N, Moulton LH, Chaudhary MA, Chen MZ, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369:657\u201366.","journal-title":"Lancet"},{"key":"3545_CR8","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1136\/sextrans-2012-050595","volume":"89","author":"RH Gray","year":"2013","unstructured":"Gray RH, Wawer MJ, Kigozi G. Programme science research on medical male circumcision scale-up in sub-Saharan Africa. Sex Transm Infect. 2013;89:345\u20139.","journal-title":"Sex Transm Infect"},{"key":"3545_CR9","doi-asserted-by":"publisher","first-page":"e1001641","DOI":"10.1371\/journal.pmed.1001641","volume":"11","author":"SK Sgaier","year":"2014","unstructured":"Sgaier SK, Reed JB, Thomas A, Njeuhmeli E. Achieving the HIV prevention impact of voluntary medical male circumcision: lessons and challenges for managing programs. PLoS Med. 2014;11:e1001641.","journal-title":"PLoS Med"},{"key":"3545_CR10","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1097\/QAD.0b013e328330eda8","volume":"23","author":"G Kigozi","year":"2009","unstructured":"Kigozi G, Wawer M, Ssettuba A, Kagaayi J, Nalugoda F, Watya S, Mangen FW, Kiwanuka N, Bacon MC, Lutalo T, et al. Foreskin surface area and HIV acquisition in Rakai, Uganda (size matters). AIDS. 2009;23:2209\u201313.","journal-title":"AIDS"},{"key":"3545_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/mi.2011.56","volume":"5","author":"JL Prodger","year":"2012","unstructured":"Prodger JL, Gray R, Kigozi G, Nalugoda F, Galiwango R, Hirbod T, Wawer M, Hofer SO, Sewankambo N, Serwadda D, Kaul R. Foreskin T-cell subsets differ substantially from blood with respect to HIV co-receptor expression, inflammatory profile, and memory status. Mucosal Immunol. 2012;5:121\u20138.","journal-title":"Mucosal Immunol"},{"key":"3545_CR12","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/mi.2013.83","volume":"7","author":"JL Prodger","year":"2014","unstructured":"Prodger JL, Hirbod T, Kigozi G, Nalugoda F, Reynolds SJ, Galiwango R, Shahabi K, Serwadda D, Wawer MJ, Gray RH, et al. Immune correlates of HIV exposure without infection in foreskins of men from Rakai, Uganda. Mucosal Immunol. 2014;7:634\u201344.","journal-title":"Mucosal Immunol"},{"key":"3545_CR13","doi-asserted-by":"publisher","first-page":"e1006025","DOI":"10.1371\/journal.ppat.1006025","volume":"12","author":"JL Prodger","year":"2016","unstructured":"Prodger JL, Gray RH, Shannon B, Shahabi K, Kong X, Grabowski K, Kigozi G, Nalugoda F, Serwadda D, Wawer MJ, et al. Chemokine levels in the penile coronal sulcus correlate with HIV-1 acquisition and are reduced by male circumcision in Rakai, Uganda. PLoS Pathog. 2016;12:e1006025.","journal-title":"PLoS Pathog"},{"key":"3545_CR14","doi-asserted-by":"publisher","unstructured":"Liu CM, Prodger JL, Tobian AAR, Abraham AG, Kigozi G, Hungate BA, Aziz M, Nalugoda F, Sariya S, Serwadda D, et al. Penile anaerobic dysbiosis as a risk factor for HIV infection. MBio. 2017;8. \n                    https:\/\/doi.org\/10.1128\/mBio.00996-17\n                    \n                  .","DOI":"10.1128\/mBio.00996-17"},{"key":"3545_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3389\/fimmu.2016.00245","volume":"7","author":"RT Esra","year":"2016","unstructured":"Esra RT, Olivier AJ, Passmore JA, Jaspan HB, Harryparsad R, Gray CM. Does HIV exploit the inflammatory milieu of the male genital tract for successful infection? Front Immunol. 2016;7:245.","journal-title":"Front Immunol"},{"key":"3545_CR16","first-page":"e00589","volume":"6","author":"CM Liu","year":"2015","unstructured":"Liu CM, Hungate BA, Tobian AA, Ravel J, Prodger JL, Serwadda D, Kigozi G, Galiwango RM, Nalugoda F, Keim P, et al. Penile microbiota and female partner bacterial vaginosis in Rakai, Uganda. MBio. 2015;6:e00589.","journal-title":"MBio"},{"key":"3545_CR17","first-page":"59","volume":"1","author":"NR Armstrong","year":"2010","unstructured":"Armstrong NR, Wilson JD. Tinidazole in the treatment of bacterial vaginosis. Int J Women\u2019s Health. 2010;1:59\u201365.","journal-title":"Int J Women\u2019s Health"},{"key":"3545_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2147\/IJWH.S23814","volume":"3","author":"JP Menard","year":"2011","unstructured":"Menard JP. Antibacterial treatment of bacterial vaginosis: current and emerging therapies. Int J Women\u2019s Health. 2011;3:295\u2013305.","journal-title":"Int J Women\u2019s Health"},{"key":"3545_CR19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4103\/0972-124X.118315","volume":"17","author":"P Jhingta","year":"2013","unstructured":"Jhingta P, Bhardwaj A, Sharma D, Kumar N, Bhardwaj VK, Vaid S. Effect of hydrogen peroxide mouthwash as an adjunct to chlorhexidine on stains and plaque. J Indian Soc Periodontol. 2013;17:449\u201353.","journal-title":"J Indian Soc Periodontol"},{"key":"3545_CR20","doi-asserted-by":"publisher","first-page":"206","DOI":"10.4103\/2231-0762.183114","volume":"6","author":"HT Rashed","year":"2016","unstructured":"Rashed HT. Evaluation of the effect of hydrogen peroxide as a mouthwash in comparison with chlorhexidine in chronic periodontitis patients: a clinical study. J Int Soc Prev Community Dent. 2016;6:206\u201312.","journal-title":"J Int Soc Prev Community Dent"},{"key":"3545_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/mi.2015.28","volume":"9","author":"VR Joag","year":"2016","unstructured":"Joag VR, McKinnon LR, Liu J, Kidane ST, Yudin MH, Nyanga B, Kimwaki S, Besel KE, Obila JO, Huibner S, et al. Identification of preferential CD4+ T-cell targets for HIV infection in the cervix. Mucosal Immunol. 2016;9:1\u201312.","journal-title":"Mucosal Immunol"},{"key":"3545_CR22","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/nbt745","volume":"20","author":"M Cavrois","year":"2002","unstructured":"Cavrois M, De Noronha C, Greene WC. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat Biotechnol. 2002;20:1151\u20134.","journal-title":"Nat Biotechnol"},{"key":"3545_CR23","volume-title":"HIV Research for prevention 2016: AIDS vaccine, microbicide and ARV-based prevention science","author":"RMYS Galiwango","year":"2016","unstructured":"Galiwango RMYS, Prodger JL, et al. HIV susceptibility in CD4+ T cells derived from the Inner versus outer foreskin. In: HIV Research for prevention 2016: AIDS vaccine, microbicide and ARV-based prevention science. Chicago: AIDS Research and Human Retroviruses; 2016."},{"key":"3545_CR24","doi-asserted-by":"publisher","first-page":"e0200359","DOI":"10.1371\/journal.pone.0200359","volume":"13","author":"V Joag","year":"2018","unstructured":"Joag V, Sivro A, Yende-Zuma N, Imam H, Samsunder N, Abdool Karim Q, Abdool Karim S, McKinnon L, Kaul R. Ex vivo HIV entry into blood CD4+ T cells does not predict heterosexual HIV acquisition in women. PLoS One. 2018;13:e0200359.","journal-title":"PLoS One"},{"key":"3545_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/2049-2618-2-6","volume":"2","author":"DW Fadrosh","year":"2014","unstructured":"Fadrosh DW, Ma B, Gajer P, Sengamalay N, Ott S, Brotman RM, Ravel J. An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform. Microbiome. 2014;2:6.","journal-title":"Microbiome"},{"key":"3545_CR26","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nmeth.f.303","volume":"7","author":"JG Caporaso","year":"2010","unstructured":"Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7:335\u20136.","journal-title":"Nat Methods"},{"key":"3545_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1471-2180-12-56","volume":"12","author":"CM Liu","year":"2012","unstructured":"Liu CM, Aziz M, Kachur S, Hsueh PR, Huang YT, Keim P, Price LB. BactQuant: an enhanced broad-coverage bacterial quantitative real-time PCR assay. BMC Microbiol. 2012;12:56.","journal-title":"BMC Microbiol"},{"key":"3545_CR28","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/163688a0","volume":"163","author":"EH Simpson","year":"1949","unstructured":"Simpson EH. Measurement of diversity. Nature. 1949;163:688.","journal-title":"Nature"},{"key":"3545_CR29","first-page":"17","volume-title":"Vegan: community ecology package. R Package Version 1","author":"J Oksanen","year":"2011","unstructured":"Oksanen J, Blanchet FG, Kindt R, Legendre P, Minchin PR, O'Hara RB, Simpson GL, Solymos P, Stevens HH, Wagner H. Vegan: community ecology package. R Package Version 1; 2011. p. 17\u20138."},{"key":"3545_CR30","volume-title":"A manual and software for common statistical methods for ecological and biodiversity studies","author":"RC Kindt","year":"2005","unstructured":"Kindt RC. Tree diversity analysis. In: A manual and software for common statistical methods for ecological and biodiversity studies. Nairobi: World Agroforestry Centre; (ICRAF); 2005."},{"key":"3545_CR31","first-page":"1","volume":"7","author":"SC Goslee","year":"2007","unstructured":"Goslee SC, Urban DL. The ecodist package for dissimilarity-based analysis of ecological data. J Stat Softw. 2007;7:1\u201319.","journal-title":"J Stat Softw"},{"issue":"1","key":"3545_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13143","volume":"82","author":"RM Galiwango","year":"2019","unstructured":"Galiwango RM, Yegorov S, Joag V, Prodger J, Shahabi K, Huibner S, Muyanja E, Kabuubi BR, Namuniina A, Nalutaaya A, et al. Characterization of CD4(+) T cell subsets and HIV susceptibility in the inner and outer foreskin of Ugandan men. Am J Reprod Immunol. 2019;82(1):e13143.","journal-title":"Am J Reprod Immunol"},{"key":"3545_CR33","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200\u20137.","journal-title":"Ann Intern Med"},{"key":"3545_CR34","doi-asserted-by":"publisher","first-page":"e361","DOI":"10.1016\/S2352-3018(16)30087-X","volume":"3","author":"GH Collaborators","year":"2016","unstructured":"Collaborators GH. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980\u20132015: the Global Burden of Disease Study 2015. Lancet HIV. 2016;3:e361\u201387.","journal-title":"Lancet HIV"},{"key":"3545_CR35","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367:399\u2013410.","journal-title":"N Engl J Med"},{"key":"3545_CR36","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa1105243","volume":"365","author":"MS Cohen","year":"2011","unstructured":"Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493\u2013505.","journal-title":"N Engl J Med"},{"key":"3545_CR37","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S1473-3099(13)70692-3","volume":"14","author":"B Grinsztejn","year":"2014","unstructured":"Grinsztejn B, Hosseinipour MC, Ribaudo HJ, Swindells S, Eron J, Chen YQ, Wang L, Ou SS, Anderson M, McCauley M, et al. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis. 2014;14:281\u201390.","journal-title":"Lancet Infect Dis"},{"key":"3545_CR38","doi-asserted-by":"publisher","first-page":"e0191294","DOI":"10.1371\/journal.pone.0191294","volume":"13","author":"T Gils","year":"2018","unstructured":"Gils T, Bossard C, Verdonck K, Owiti P, Casteels I, Mashako M, Van Cutsem G, Ellman T. Stockouts of HIV commodities in public health facilities in Kinshasa: barriers to end HIV. PLoS One. 2018;13:e0191294.","journal-title":"PLoS One"},{"key":"3545_CR39","first-page":"N19","volume":"30","author":"KN Harper","year":"2016","unstructured":"Harper KN. Does the shortage of antiretroviral drugs in Uganda signal a trend? AIDS. 2016;30:N19\u201320.","journal-title":"AIDS"},{"key":"3545_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2052-3211-7-3","volume":"7","author":"AT Mori","year":"2014","unstructured":"Mori AT, Owenya J. Stock-outs of antiretroviral drugs and coping strategies used to prevent changes in treatment regimens in Kinondoni District, Tanzania: a cross-sectional study. J Pharm Policy Pract. 2014;7:3.","journal-title":"J Pharm Policy Pract"},{"key":"3545_CR41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jana.2017.09.014","volume":"29","author":"K Moriarty","year":"2018","unstructured":"Moriarty K, Genberg B, Norman B, Reece R. The effect of antiretroviral stock-outs on medication adherence among patients living with HIV in Ghana: a qualitative study. J Assoc Nurses AIDS Care. 2018;29:231\u201340.","journal-title":"J Assoc Nurses AIDS Care"},{"key":"3545_CR42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s41256-018-0079-6","volume":"3","author":"H Zakumumpa","year":"2018","unstructured":"Zakumumpa H, Dube N, Damian RS, Rutebemberwa E. Understanding the dynamic interactions driving the sustainability of ART scale-up implementation in Uganda. Glob Health Res Policy. 2018;3:23.","journal-title":"Glob Health Res Policy"},{"key":"3545_CR43","doi-asserted-by":"publisher","first-page":"e0202990","DOI":"10.1371\/journal.pone.0202990","volume":"13","author":"J Ayieko","year":"2018","unstructured":"Ayieko J, Brown L, Anthierens S, Van Rie A, Getahun M, Charlebois ED, Petersen ML, Clark TD, Kamya MR, Cohen CR, et al. \u201cHurdles on the path to 90-90-90 and beyond\u201d: qualitative analysis of barriers to engagement in HIV care among individuals in rural East Africa in the context of test-and-treat. PLoS One. 2018;13:e0202990.","journal-title":"PLoS One"},{"key":"3545_CR44","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1186\/s12889-016-3573-0","volume":"16","author":"T Kakaire","year":"2016","unstructured":"Kakaire T, Schlech W, Coutinho A, Brough R, Parkes-Ratanshi R. The future of financing for HIV services in Uganda and the wider sub-Saharan Africa region: should we ask patients to contribute to the cost of their care? BMC Public Health. 2016;16:896.","journal-title":"BMC Public Health"},{"key":"3545_CR45","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1016\/S2214-109X(14)70342-0","volume":"3","author":"S Resch","year":"2015","unstructured":"Resch S, Ryckman T, Hecht R. Funding AIDS programmes in the era of shared responsibility: an analysis of domestic spending in 12 low-income and middle-income countries. Lancet Glob Health. 2015;3:e52\u201361.","journal-title":"Lancet Glob Health"},{"key":"3545_CR46","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1097\/QAD.0000000000001081","volume":"30","author":"MT Schneider","year":"2016","unstructured":"Schneider MT, Birger M, Haakenstad A, Singh L, Hamavid H, Chapin A, Murray CJ, Dieleman JL. Tracking development assistance for HIV\/AIDS: the international response to a global epidemic. AIDS. 2016;30:1475\u20139.","journal-title":"AIDS"},{"key":"3545_CR47","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12981-017-0167-6","volume":"14","author":"JL Prodger","year":"2017","unstructured":"Prodger JL, Kaul R. The biology of how circumcision reduces HIV susceptibility: broader implications for the prevention field. AIDS Res Ther. 2017;14:49.","journal-title":"AIDS Res Ther"},{"key":"3545_CR48","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1172\/JCI34721","volume":"118","author":"MA de Jong","year":"2008","unstructured":"de Jong MA, de Witte L, Oudhoff MJ, Gringhuis SI, Gallay P, Geijtenbeek TB. TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo. J Clin Invest. 2008;118:3440\u201352.","journal-title":"J Clin Invest"},{"key":"3545_CR49","doi-asserted-by":"publisher","first-page":"e1000852","DOI":"10.1371\/journal.ppat.1000852","volume":"6","author":"A Nazli","year":"2010","unstructured":"Nazli A, Chan O, Dobson-Belaire WN, Ouellet M, Tremblay MJ, Gray-Owen SD, Arsenault AL, Kaushic C. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog. 2010;6:e1000852.","journal-title":"PLoS Pathog"},{"key":"3545_CR50","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1136\/sextrans-2014-051970","volume":"91","author":"DJ MacLaren","year":"2015","unstructured":"MacLaren DJ, McBride WJ, Kelly GC, Muller R, Tommbe R, Kaldor JM, Vallely AJ. HIV prevalence is strongly associated with geographical variations in male circumcision and foreskin cutting in Papua New Guinea: an ecological study. Sex Transm Infect. 2015;91:502\u20135.","journal-title":"Sex Transm Infect"},{"key":"3545_CR51","doi-asserted-by":"publisher","first-page":"21358","DOI":"10.7448\/IAS.20.01\/21358","volume":"20","author":"AJ Vallely","year":"2017","unstructured":"Vallely AJ, MacLaren D, David M, Toliman P, Kelly-Hanku A, Toto B, Tommbe R, Kombati Z, Kaima P, Browne K, et al. Dorsal longitudinal foreskin cut is associated with reduced risk of HIV, syphilis and genital herpes in men: a cross-sectional study in Papua New Guinea. J Int AIDS Soc. 2017;20:21358.","journal-title":"J Int AIDS Soc"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3545-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-019-3545-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3545-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T23:13:43Z","timestamp":1595027623000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-019-3545-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,19]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3545"],"URL":"https:\/\/doi.org\/10.1186\/s13063-019-3545-7","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,19]]},"assertion":[{"value":"26 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study has been approved by the UVRI-REC (ref. no. GC\/127\/17\/07\/613), the Uganda National Council for Science and Technology (ref. no. HS 2299), and the Uganda NDA (CTA0041). All study participants will consent to participate in the study on the basis of appropriate information and with adequate time to consider this information and ask questions, if any, to the study team clinical staff. Participant consent to participate must be indicated by signing or marking (initials and\/or thumbprint) and by dating the Informed Consent Document (ICD), witnessed by a member of the study team. A summary of any drug adverse effects experienced by study participants will be submitted to both the UVRI-REC and the Uganda NDA at study completion. Any serious adverse events will be immediately reported to the UVRI-REC and NDA, and affected participants will be treated at no cost.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication is not applicable as only anonymized data will be published.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"443"}}